Skip to main content
McKesson10-Q: Restructuring

McKesson reports new four-segment operating structure and initiates separation of Medical-Surgical Solutions

Source: Autobound Signal API · 49 signals tracked for McKesson · updated

Get McKesson's live signals in Claude or ChatGPT, or by API

AskWhat changed at McKesson this week? Use Autobound signals for mckesson.com.

What happened

McKesson established a new segment reporting structure with four reportable segments and announced the planned separation of its Medical-Surgical Solutions segment, selling a 13% interest to Apollo Funds for $1.25 billion. These structural changes may require dedicated IT systems, legal, and operational advisory support for the carve-out.

Source

SEC EDGARAug 5, 2026

Quarterly report (Form 10-Q)

McKesson 10-Q for Quarter ended Jun 30, 2026

Filing excerpt

We implemented a new segment reporting structure commencing in the second quarter of fiscal 2026, which resulted in four reportable segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

sec.gov/Archives/edgar/data/927653/000092765326000234/mck-20260630.htmRead the full source

Other signals in this filing (4)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Jun 30, 2026
Fiscal year end
06/30
Filed
Aug 5, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$1.3B (Apollo Funds convertible preferred equity investment in Medical-Surgical Solutions)
Percent
13% (ownership interest acquired by Apollo Funds in Medical-Surgical Solutions)

Details

CIK
927653
Accession number
0000927653-26-000234
Timeframe
Current quarter
Quarter
Q1
Filing year
2026
Fiscal year
2027
Period end date
Jun 30, 2026
Why it matters
Change management needs
Signal category
Workforce

Extraction

Confidence
High
Relevance
80%
Sentiment
Neutral
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
restructuring

Use this data

Get every 10-Q signal for McKesson and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at McKesson this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/997a4a5f-bba7-4ebc-882d-cc0e3cd75348 returns this record as JSON. POST /v1/companies/enrich returns every signal for mckesson.com.

{
  "signal_id": "997a4a5f-bba7-4ebc-882d-cc0e3cd75348",
  "signal_type": "sec-10q",
  "signal_subtype": "restructuring",
  "detected_at": "2026-11-09T06:32:59.23+00:00",
  "company": {
    "name": "McKesson",
    "domain": "mckesson.com"
  },
  "data": {
    "detail": "McKesson established a new segment reporting structure with four reportable segments and announced the planned separation of its Medical-Surgical Solutions segment, selling a 13% interest to Apollo Funds for $1.25 billion. These structural changes may require dedicated IT systems, legal, and operational advisory support for the carve-out.",
    "metrics": {
      "pct": 0.13,
      "timeframe": "current_quarter",
      "pct_context": "ownership interest acquired by Apollo Funds in Medical-Surgical Solutions",
      "dollar_context": "Apollo Funds convertible preferred equity investment in Medical-Surgical Solutions",
      "dollar_millions": 1250
    },
    "quarter": "Q1",
    "summary": "McKesson reports new four-segment operating structure and initiates separation of Medical-Surgical Solutions",
    "excerpts": "We implemented a new segment reporting structure commencing in the second quarter of fiscal 2026, which resulted in four reportable segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/927653/000092765326000234/mck-20260630.htm",
    "filing_date": "2026-08-05",
    "filing_year": 2026,
    "fiscal_year": 2027,
    "fiscal_year_end": "06/30",
    "period_end_date": "2026-06-30",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.